Form D · Biotechnology

BioAtla,LLC

San Diego, CA · CIK 0001614452

Offering snapshot reported Jul 21, 2015 · SEC filing

Reported sold
$5.81M
Offering amount: $5.81M
Investors reported
53
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 11, 2014
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.91M$5.81MJul 22, 2014: $3,110,000.00Jul 22, 2014Jul 21, 2015: $5,810,000.00Jul 21, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,110,000 → $5,810,000
  • Reported investors42 → 53

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 21, 2015Amendment$5,810,000$2,700,000vs Jul 22, 201453SEC filing
Jul 21, 2015Initial$39,000,001No comparison3SEC filing
Jul 22, 2014Initial$3,110,000No comparison42SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-221527

Source: Form D, filed Jul 21, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jay M. Short Director, Executive
Carolyn Short Director
Richard A. Waldron Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
11011 Torreyana Road
San Diego, CA, 92121